Examinations
Process patent infringement: how is it proved that a product was made by the patented method?
A process patent is infringed when someone performs the claimed method in the United States, or imports, sells or uses a product made by it. The method usually runs inside the defendant's plant, often abroad. Section 295 of the Patent Act shifts the burden to the defendant when a product was likely made by the process and the owner could not find out how it was made. The technical expert works on both questions.

What acts infringe a process patent?
Performing the claimed process in the United States, and importing, offering to sell, selling or using in the United States a product made by the process, during the patent term. The second group comes from 35 U.S.C. 271(g).
Section 271(a) of the Patent Act covers anyone who "without authority makes, uses, offers to sell, or sells any patented invention, within the United States or imports into the United States any patented invention during the term of the patent therefor." A process is an invention that is used by carrying it out, so the defendant who runs the claimed steps in a U.S. plant infringes under that subsection.
Section 271(g) reaches the product. It reads: "Whoever without authority imports into the United States or offers to sell, sells, or uses within the United States a product which is made by a process patented in the United States shall be liable as an infringer, if the importation, offer to sell, sale, or use of the product occurs during the term of such process patent."
The two routes call for different proof. Under 271(a) the patent owner proves that each step of the claim is performed in the United States. Under 271(g) the patent owner proves that the product was made by the claimed process, wherever that happened, and that the product was imported, sold, offered or used here. In both, the expert compares the claim step by step with what the defendant or its supplier actually does.
Why is a process patent harder to prove than a product patent?
Because the evidence is in the defendant's or the supplier's plant. A product can be bought and tested, but the steps used to make it often leave no visible trace, and the plant may be abroad.
A product claim is compared with the product: the expert buys a sample, takes it apart or analyzes it, and charts each element against what is found. A process claim describes steps, temperatures, reagents, sequences or conditions. Many of them leave nothing in the finished product that a laboratory can read.
Discovery fills part of the gap. Batch records, manufacturing instructions, regulatory filings and testimony of plant engineers show how the product is made. When the manufacturer is a foreign supplier that is not a party, those records may be out of reach. The importer in the United States may hold only certificates of analysis and specifications, which describe the product but not the steps that made it.
Congress addressed that situation in 35 U.S.C. 295. The section applies when the patent owner has tried to find out how the product was made and could not, and it moves the burden of proof to the party who says the product was not made by the patented process.
When does 35 U.S.C. 295 shift the burden of proof to the defendant?
When the court finds that a substantial likelihood exists that the product was made by the patented process and that the plaintiff made a reasonable effort to determine the process actually used and was unable to do so.
The full text of section 295 reads: "In actions alleging infringement of a process patent based on the importation, sale, offer for sale, or use of a product which is made from a process patented in the United States, if the court finds- (1) that a substantial likelihood exists that the product was made by the patented process, and (2) that the plaintiff has made a reasonable effort to determine the process actually used in the production of the product and was unable to so determine, the product shall be presumed to have been so made, and the burden of establishing that the product was not made by the process shall be on the party asserting that it was not so made."
Both conditions are findings of the court. The first concerns the product: the evidence must make it substantially likely that the claimed process produced it. The second concerns the patent owner's conduct: it must have tried to learn the actual process and failed. Only then is the product presumed to have been made by the patented process.
The presumption moves the burden of establishing that the product was not made by the process. The defendant then has to prove its own process, with records, samples and testimony, and the patent owner's expert tests that proof against the claim.
How does an expert build the substantial likelihood under section 295?
From the product and the public record: the composition, impurities and physical properties found in the product, compared with what the claimed process produces and with what other known processes would produce.
Section 295 does not say how the likelihood is shown, so the evidence is technical. The expert analyzes samples of the accused product and states which measured features are consistent with the claimed steps. Where other known processes would leave different features, the report explains why the measurements point to the claimed process and not to the alternatives.
The report names the method of each analysis, the samples and the batches. Rule 26(a)(2)(B) of the Federal Rules of Civil Procedure requires "a complete statement of all opinions the witness will express and the basis and reasons for them" and "the facts or data considered by the witness in forming them." An opinion that the product was "likely" made by the process, without the measurements and the comparison with alternatives, does not give the court a finding to make.
Rule 702 of the Federal Rules of Evidence sets the admissibility test. Since the 2023 amendment, the proponent must show the court that it is more likely than not that the testimony rests on sufficient facts or data, comes from reliable principles and methods, and applies them reliably to the case. The committee note adds that "each expert opinion must stay within the bounds of what can be concluded from a reliable application of the expert's basis and methodology."
What counts as a reasonable effort to determine the process?
Section 295 does not define it. The patent owner shows what it did to learn the actual process, such as discovery requests, attempts to reach the supplier and product analysis, and why that did not reveal the process.
The second finding looks at the patent owner's conduct, not at the product. A record of requests for manufacturing documents, the answers received, any refusal by a foreign supplier, and the technical analysis that was attempted is the evidence the court weighs. The statute requires that the patent owner "was unable to so determine," so the effort has to be both reasonable and unsuccessful.
The expert has a part in this record too. A report that describes the tests run on the product and explains why they cannot reveal certain steps of the process supports the finding that the owner tried and could not determine the process from the product alone.
If the effort succeeds, the presumption is not needed. When discovery produces the defendant's or the supplier's batch records, the expert compares the claim with those records directly, and the case proceeds on ordinary proof.
Is importing a product made abroad by the patented process an infringement?
Yes, under 271(g). In Syngenta v. Willowood (2019) the Federal Circuit held that practicing the process abroad does not itself create liability; liability attaches to acts in the United States with respect to the product made by the process.
Syngenta Crop Protection, LLC v. Willowood, LLC, Nos. 2018-1614 and 2018-2044, was decided on December 18, 2019, with Judge Reyna writing for a panel of Judges Reyna, Taranto and Stoll. The patent, the '138 patent, claimed a two-step process for manufacturing azoxystrobin. The opinion records the district court's finding that Willowood's Chinese supplier, Yangcheng Tai He Chemicals Corp., made the azoxystrobin by performing both steps of the claimed process.
The court read 271(g) as aimed at the product: "Nothing in this statutory language suggests that liability arises from practicing the patented process abroad. Rather, the focus is only on acts with respect to products resulting from the patented process."
The court reversed the district court's judgment that Willowood USA did not infringe the '138 patent. For the expert, the comparison in a 271(g) case concerns the process used by the foreign supplier, and the acts in the United States are shown by import and sales records.
Must one company perform all the steps of the process?
Not under 271(g). Syngenta held that 271(g) does not require a single entity to perform all of the steps of a patented process for infringement liability.
The Federal Circuit rejected a single-entity requirement for 271(g). It wrote that "whether that process is practiced by a single entity is immaterial to the infringement analysis under that section," and held that "§ 271(g) does not require a single entity to perform all of the steps of a patented process for infringement liability to arise".
This changes what the expert has to trace. Where one supplier performs the first step and another performs the second, the report traces the intermediate through each plant in turn and proves that the steps together match the claim. The question of who performed each step goes to the facts of the chain, not to whether 271(g) applies.
The chain is also where the defense looks first. A gap in the documents between the intermediate and the final product, or an intermediate bought from a third source, is a point the defendant's expert will press, and the patent owner's report addresses it before deposition.
When does a later process take the product outside 271(g)?
When the product is materially changed by subsequent processes or becomes a trivial and nonessential component of another product. In Eli Lilly v. American Cyanamid (1996) the court refused to read the material-change exception the patent owner's way.
Section 271(g) ends with two exceptions: "A product which is made by a patented process will, for purposes of this title, not be considered to be so made after- (1) it is materially changed by subsequent processes; or (2) it becomes a trivial and nonessential component of another product."
In Eli Lilly & Co. v. American Cyanamid Co., 82 F.3d 1568 (Fed. Cir. 1996), Judge Bryson wrote for the court. Lilly held a process patent on the production of an intermediate, compound 6, and sought a preliminary injunction against imports of the antibiotic cefaclor, made in Italy from compound 6 by four further chemical steps. Lilly argued that the conversion was not a material change, relying on the commercial link between compound 6 and cefaclor. The court compared the structures of the two compounds and wrote: "We therefore do not adopt Lilly's proposed construction of section 271(g)." It affirmed the denial of the injunction.
For the expert, the exception turns the comparison into chemistry or engineering. The report describes each step between the patented product and the imported one, what each step changes in structure or properties, and why the change is or is not material. A report that relies only on commercial relationships between the two products answers a question Eli Lilly declined to adopt.
Can the patent owner sue users and retailers of the imported product?
Only in a limited way. Under 271(g), no remedy is granted for noncommercial use or retail sale of the product unless there is no adequate remedy against its importation, other use, offer to sell or sale.
The statute reads: "In an action for infringement of a process patent, no remedy may be granted for infringement on account of the noncommercial use or retail sale of a product unless there is no adequate remedy under this title for infringement on account of the importation or other use, offer to sell, or sale of that product."
The patent owner therefore aims at the importer and the commercial seller first. Import records, customs data produced in discovery and sales records identify those parties, and the expert's analysis of samples bought in the market ties the product to the claimed process.
Damages and injunctions follow the usual rules. The technical expert's work ends with the question whether the product was made by the claimed process; the amount of a royalty or lost profits is the work of a damages expert.
How does the defendant rebut the presumption?
By proving the process it actually used. Once the presumption applies, the defendant carries the burden of establishing that the product was not made by the patented process, so its own records and its expert decide the point.
Section 295 places "the burden of establishing that the product was not made by the process" on "the party asserting that it was not so made." The defendant answers with batch records, process descriptions, supplier certifications and testimony of the people who run the process, and its expert explains why that process falls outside the claim.
The patent owner's expert then tests the defendant's account. The questions are whether the documents describe the process actually used for the accused batches, whether the described process would produce a product with the measured features, and whether any step of the described process is an equivalent of a claimed step.
A defendant's report that describes a process in general terms, without tying it to the dates and batches of the imported product, leaves the burden unmet. The patent owner's rebuttal report, due within 30 days of the other side's disclosure under Rule 26(a)(2)(D)(ii) unless the court orders otherwise, points to each such gap.
How long does a process patent last, and when do the acts have to occur?
Twenty years from the filing date under 35 U.S.C. 154(a)(2), subject to adjustment. Section 271(g) applies only if the importation, offer to sell, sale or use of the product occurs during the term of the process patent.
Under 35 U.S.C. 154(a)(2), the term ends "20 years from the date on which the application for the patent was filed in the United States," or from the earliest referenced application. Section 154(b) provides for adjustment of the term, so the expiration date is taken from the patent record.
The timing rule in 271(g) is tied to the acts in the United States, not to the date of manufacture. Its text requires that "the importation, offer to sell, sale, or use of the product occurs during the term of such process patent." The expert's report therefore identifies the batches by date of import or sale, and the comparison covers the process used for those batches.
What does the technical expert compare in a process case?
Each step of the claim, as construed by the court, with the defendant's or the supplier's actual process as shown by records, samples and testimony, or, where those are missing, with what the product analysis reveals.
The chart lists each step and limitation of the claim: reagents, order, temperatures, pressures, times, intermediates. Beside each one, the expert cites the batch record, the manufacturing instruction or the testimony that shows how the defendant performs it, and marks the step as performed, performed by an equivalent, or not performed.
Where the records are missing, the chart cites product analysis instead and explains what each measurement says about the steps. Where section 295 is in play, the report states separately the facts that support a substantial likelihood and the facts about the attempts to learn the process.
The same chart serves the deposition: each row is a question about one step, and the defendant's witnesses either confirm the record or explain a difference. Where the product was further processed, the report adds the 271(g) exceptions: every later step, what it changes and whether the patented product survives into the imported one in a form that is not materially changed and not a trivial component.
Communications with counsel are protected, except that facts, data and assumptions supplied by counsel are discoverable under Rule 26(b)(4)(C). A report that assumes a claim construction or a supplier's identity supplied by counsel says so.
What does IAE do in a process patent dispute?
An IAE expert prepares a report on whether the defendant's process meets each element of the claim, literally or by equivalents, or a review of the opposing technical report, in up to 5 business days.
The patent expertise page describes the infringement work as claim charts that map each claim element to the accused product, with equivalents tested element by element, and lists making, using, selling and importing as the acts under 35 U.S.C. 271(a). For a process claim, the chart maps each step to the defendant's documents or to the product analysis.
IAE chooses the expert by the technical field of the patent and confirms the patent, the asserted claims and the questions before work starts. The client sends the patent, the claim construction if there is one, the samples or test results and the documents produced in discovery that it may share under the protective order. The secretariat confirms receipt the same day. Within one business day IAE confirms the format, the cost, the deadline and the expert from its registry, and the client approves the candidate and the CV. The signed PDF is issued in up to 5 business days, with a 48-hour rush for tight deadlines.
Every expert is a member of the public IAE registry, verifiable by Member ID or QR code, and states in the document that he or she has no interest in the outcome. A report is evidence that the court weighs with the other evidence, and neither IAE nor the expert guarantees the outcome. IAE is not a law firm and does not advise on case strategy.
Sources
- 35 U.S. Code 271, Infringement of patent (LII, Cornell Law School)
- 35 U.S. Code 295, Presumption: Product made by patented process (LII, Cornell Law School)
- 35 U.S. Code 154, Contents and term of patent (LII, Cornell Law School)
- Syngenta Crop Protection, LLC v. Willowood, LLC, Nos. 2018-1614, -2044 (Fed. Cir. Dec. 18, 2019), opinion reproduced in the appendix to the petition in No. 19-1147 (Supreme Court of the United States)
- Eli Lilly & Co. v. American Cyanamid Co., 82 F.3d 1568 (Fed. Cir. 1996) (Justia)
- Federal Rules of Civil Procedure, Rule 26 (LII, Cornell Law School)
- Federal Rules of Evidence, Rule 702, with committee notes (LII, Cornell Law School)
Read also
All articles
Prior user rights: what must an accused infringer prove under 35 U.S.C. 273, and what does the technical expert compare?
A company that has run a process in its plant for years can be sued when someone else later patents the same process. Section 273 of the Patent Act
Patent inventorship dispute: who is an inventor, and how does the technical expert map each contribution to the claims?
An inventorship dispute asks who conceived what the claims cover. A former employee, a university collaborator or a supplier's engineer says he
Freedom to operate analysis: what does it check, and what does it change if the product is later sued?
A freedom to operate analysis asks whether a product can be made and sold in a given country without infringing patents held by others. The analystExpert examinations
Ready to discuss your case?
Send the materials: the secretariat will confirm the format, cost, deadline and the specialist within one business day.

